Primary Malignant Melanoma of Uterus and Ovary
Conditions
Interventions
None listed
Sponsors
Kansai Clinical Oncology Group (KCOG)
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Patients who received treatment for primary uterine and ovarian malignant melanoma during the 20-year period from April 1997 through March 2017
Exclusion criteria
Exclusion criteria: Metastatic uterine and ovarian malignant melanoma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prognostic Factors in primary malignant melanoma of uterus and ovary | — |
Countries
Japan
Contacts
Public ContactMitsutake Yano
Saitama Medical University International Medical Center Department of Pathology
Outcome results
None listed